The heterogeneity of cognitive symptoms in Parkinson's disease: A meta-analysis

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 84, Issue 11, 2013, Pages 1265-1272

  Tremblay, Christina ^a,b   Achim, Amélie M ^a,b   Macoir, Joël ^a,b   Monetta, Laura ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84885607683     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2013-305021     Document Type: Review

References (56)

1. Taylor AE, Saint-Cyr JA, Lang AE. Frontal lobe dysfunction in Parkinson's disease: the cortical focus of neostriatal outflow. Brain 1986;109:279-92.
2. Santamaria J, Tolosa E, Valles A. Parkinson's disease with depression: a possible subgroup of idiopathic parkinsonism. Neurology 1986;36:1130-3. (Pubitemid 16038602)
3. Owen AM. Cognitive dysfunction in Parkinson's disease: the role of frontostriatal circuitry. Neuroscientist 2004;10:525-37. (Pubitemid 39546395)
4. Verbaan D, Marinus J, Visser M, et al. Cognitive impairment in Parkinson's disease. J Neurol Neurosurg Psychiatry 2007;78:1182-7. (Pubitemid 350057278)
5. Kehagia AA, Barker RA, Robbins TW. Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease. Lancet Neurol 2010;9:1200-13.
6. Aarsland D, Larsen J P, Karlsen K, et al. Mental symptoms in Parkinson's disease are important contributors to caregiver distress. Int J Geriatr Psychiatry 1999;14:866-74. (Pubitemid 29495548)
7. Aarsland D, Bronnick K, Williams-Gray C, et al. Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology 2010;5:1062-9.
8. Monchi O, Degroot C, Mejia-Constain B, et al. Neuroimaging studies of different cognitive profiles in Parkinson's disease. Parkinsonism Relat Disord 2012;18:S77-9.
9. Mortimer JA, Jun SP, Kuskowski MA, et al. Subtypes of Parkinson's disease defined by intellectual impairment. J Neural Transm Suppl 1987;24:101-4.
10. Foltynie T, Brayne C, Barker RA. The heterogeneity of idiopathic Parkinson's disease. J Neurol 2002;249:138-45. (Pubitemid 34143467)
11. Jankovic J, McDermott M, Carter J, et al. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. Neurology 1990;40:1529-34. (Pubitemid 20351344)
12. Gibb WR, Lees AJ. A comparison of clinical and pathological features of young-and old-onset Parkinson's disease. Neurology 1988;38:1402-6.
13. Diamond SG, Markham CH, Hoehn MM, et al. Effect of age at onset on progression and mortality in Parkinson's disease. Neurology 1989;39:1187-90. (Pubitemid 19239721)
14. Ransmayr G, Poewe W, Plorer S, et al. Prognostic implications of the motor symptoms of Parkinson's disease with respect to clinical, computed tomographic and psychometric parameters. J Neural Transm 1986;67:1-14. (Pubitemid 17168327)
15. Norman S, Tröster AI, Fields JA, et al. Effects of depression and Parkinson's disease on cognitive functioning. J Neuropsychiatry Clin Neurosci 2002;14:31-6. (Pubitemid 34117020)
16. Reijnders JS, Ehrt U, Lousberg R, et al. The association between motor subtypes and psychopathology in Parkinson's disease. Parkinsonism Relat Disord 2009;15:379-82.
17. Cummings JL, Benson DF. Dementia: a clinical approach. Stoneham, MA: Butterworth-Heineman, 1992.
18. Garron DC, Klawans HL, Narin F. Intellectual functioning of persons with idiopathic parkinsonism. J Nerv Ment Dis 1972;154:445-52.
19. Marttila RJ, Rinne UK. Epidemiology of Parkinson's disease in Finland. Acta Neurol Scand 1976;54:81-102.
20. Biggins CA, Boyd JL, Harrop FM, et al. A controlled, longitudinal study of dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry 1992;55:566-71.
21. Hughes TA, Ross HF, Musa S, et al. A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease. Neurology 2000;54:1596-602. (Pubitemid 30226802)
22. Katzen HL, Levin BE, Llabre ML. Age of disease onset influences cognition in Parkinson's disease. J Int Neuropsychol Soc 1998;4:285-90. (Pubitemid 28339750)
23. Lesser RP, Fahn S, Snider SR, et al. Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapy. Neurology 1979;29:1253-60. (Pubitemid 9231590)
24. Burn DJ, Rowan EN, Allan LM, et al. Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 2006;77:585-9. (Pubitemid 43844579)
25. Tröster AI, Paolo AM, Lyons KE, et al. The influence of depression on cognition in Parkinson's disease: a pattern of impairment distinguishable from Alzheimer's disease. Neurology 1995;45:672-6.
26. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097.
27. Folstein MF, Folstein SE, McHugh PR. 'Mini-Mental State'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
28. Bugalho P, Vale J. Brief cognitive assessment in the early stages of Parkinson disease. Cogn Behav Neurol 2011;24:169-73.
29. Dubois B, Burn D, Goetz C, et al. Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord 2007;22:2314-24. (Pubitemid 351155975)
30. Fahn S, Elton R. UPDRS development committee. Unified Parkinson's Disease Rating Scale. Recent Dev Parkinsons Dis 1987;2:153-63.
31. American Psychiatric Association. Task force on nomenclature and statistics: diagnostic and statistical manual of mental disorders. 3rd edn. Washington, DC: American Psychiatric Association, 1980.
32. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
33. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-9. (Pubitemid 9136500)
34. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression scale: a preliminary report. J Psychiatr Res 1983;17:37-49.
35. Beck AT, Ward CH, Mebdelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-71.
36. Beck AT. Depression inventory. San Antonio, TX: Psychological Corporation, 1987.
37. Rosenthal R. Meta-analytic procedures for social research. Newbury Park, CA: Sage, 1991.
38. Rosenthal R, DiMatteo MR. Meta-analysis: Recent developments in quantitative methods for literature reviews. Annu Rev Psychol 2001;52:59-82. (Pubitemid 33705567)
39. Cohen J Statistical power analysis for the behavioral sciences. 2nd edn. Hillsdale, NJ: Lawrence Erlbaum Associates 1988.
40. Audet N, Gagnon R, Ladouceur R, et al. L'enseignement de l'analyse critique des publications scientifiques médicales est-il efficace? Révision des études et de leur qualité mé thodologique. Can Med Assoc J 1993;148:945-52.
41. Poynard T. Évaluation de la qualité méthodologique des essais thérapeutiques randomisés. Presse Med 1988;17:315-18. (Pubitemid 18070820)
42. Moher D, Jadad AR, Tugwell P. Assessing the quality of randomized controlled trials. Int J Technol Assess Health Care 1996;12:195-208.
43. Egger M, Davey Smith G. Misleading metaanalysis. Lessons from "an effective, safe, simple" intervention that wasn't. BMJ 1995;310:752-4.
44. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34. (Pubitemid 27387172)
45. Rojo A, Aguilar M, Garolera MT, et al. Depression in Parkinson's disease: clinical correlates and outcome. Parkinsonism Relat Disord 2003;10:23-8. (Pubitemid 37117388)
46. Lewis SJG, Barker RA. Understanding the dopaminergic deficits in Parkinson's disease: insights into disease heterogeneity. J Clin Neurosci 2009;16:620-5.
47. Huber SJ, Christy JA, Paulson GW. Cognitive heterogeneity associated with clinical subtypes of Parkinson's disease. Neuropsychiatry Neuropsychol Behav Neurol 1991;4:147-57.
48. Lewis SJ, Foltynie T, Blackwell AD, et al. Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach. J Neurol Neurosurg Psychiatry 2005;76:343-8. (Pubitemid 40299121)
49. Tremblay C, Monchi O, Hudon C, et al. Are verbal fluency and nonliteral language comprehension deficits related to depressive symptoms in Parkinson's disease? Parkinsons Dis 2012;2012:308501.
50. Wertman E, Speedie L, Shemesh Z, et al. Cognitive disturbances in parkinsonian patients with depression. Neuropsychiatry Neuropsychol Behav Neurol 1993;6: 31-7. (Pubitemid 23052996)
51. Kuzis G, Sabe L, Tiberti C, et al. Cognitive functions in major depression and Parkinson's disease. Arch Neurol 1997;54:982-6. (Pubitemid 27330407)
52. Paulus W, Jellinger K. The neuropathologic basis of different clinical subgroups of Parkinson's disease. J Neuropathol Exp Neurol 1991;50:473-755.
53. Lieberman A. Depression in Parkinson's disease: a review. Acta Neurol Scand 2006;113:1-8.
54. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-42.
55. Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment (MoCA): a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695-9. (Pubitemid 41623495)
56. Pagonabarraga J, Kulisevsky J, Llebaria G, et al. Parkinson's disease-cognitive rating scale (PD-CRS): a new cognitive scale specific for Parkinson's disease. Mov Disord 2008;23:998-1005.